4 Firms Guide Ipsen's $1.3B Clementia Pharma Deal
French pharmaceutical company Ipsen, guided by Goodwin Procter LLP and Davies Ward Phillips & Vineberg LLP, said Monday it will acquire Canadian drugmaker Clementia Pharmaceuticals, counseled by Skadden Arps Slate Meagher...To view the full article, register now.
Already a subscriber? Click here to view full article